Clin2
NCT07706777Possibly a fitNot yet recruiting

Testing a new drug for acute gout flares

Acute Gouty Arthritis

Treatments studied

Part of Bones, joints & muscles clinical trials.

This trial tests an oral medication (HRS-2129) to see if it can calm a sudden gout flare and reduce joint pain. It may help if you are currently having a moderate-to-severe gout attack and are otherwise in good health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
90 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a current, sharp attack of gout (acute gout flare).
  • Your joint pain is at least 50 out of 100 on a pain scale.
  • You have no history of severe allergies (like to certain medicines).
  • You have not been treated for an irregular heartbeat or have other heart rhythm problems.
  • Your liver and kidney function are normal (checked by your doctor).
  • You do not have poorly controlled high blood pressure or nervous system/mental illness.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07145229Recruiting· Phase 2
Testing a new drug for acute gout flares

This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.

Peoria, Arizona
NCT06414837Not yet recruiting· Phase 3
New tablet for gout and high uric acid

This trial tests a new tablet (HR091506) for adults with gout and high uric acid. It aims to lower uric acid levels and reduce gout attacks, especially for people with more severe gout (like tophi or frequent attacks).

NCT07498647Not yet recruiting· Phase 2
Testing a new gout medicine for people with high uric acid

This trial tests a new tablet called BR2251 for people with gout and high uric acid. It aims to lower uric acid levels and manage gout symptoms.

NCT05658575Recruiting· Phase 2/Phase 3
Tablets to treat sudden gout flare pain

This trial studies dapansutrile tablets (OLT1177) to see how well they work for people in the first 4 days of an acute gout flare. It may help reduce pain and inflammation in the specific joint where your gout is flaring.

Birmingham, Alabama
NCT07351968Recruiting· Phase 1
Study of HRS-2129 for knee osteoarthritis pain

This trial tests an investigational drug, HRS-2129, for people with knee osteoarthritis who have moderate to severe pain. It aims to see if the drug is safe and effective at reducing pain.

Nanjing, Jiangsu
NCT06629376Recruiting· Phase 1
Testing a new gout drug for safety and effect on uric acid

This trial tests an experimental drug, SSS11, to see if it is safe and how it affects uric acid levels in people with gout and high uric acid. You may not take other gout medicines during the study.

Shanghai

Hear when a new Acute Gouty Arthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.